I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 9 studies | 27% ± 10% | |
| oligodendrocyte precursor cell | 8 studies | 30% ± 14% | |
| oligodendrocyte | 8 studies | 28% ± 9% | |
| GABAergic neuron | 7 studies | 39% ± 20% | |
| CD16-negative, CD56-bright natural killer cell, human | 6 studies | 18% ± 3% | |
| glutamatergic neuron | 6 studies | 43% ± 24% | |
| interneuron | 6 studies | 37% ± 22% | |
| microglial cell | 6 studies | 24% ± 6% | |
| astrocyte | 6 studies | 32% ± 10% | |
| naive thymus-derived CD8-positive, alpha-beta T cell | 5 studies | 20% ± 2% | |
| epithelial cell | 5 studies | 25% ± 3% | |
| macrophage | 5 studies | 22% ± 5% | |
| neuron | 4 studies | 27% ± 11% | |
| CD8-positive, alpha-beta T cell | 4 studies | 17% ± 2% | |
| endothelial cell of lymphatic vessel | 4 studies | 19% ± 4% | |
| CD4-positive, alpha-beta T cell | 3 studies | 20% ± 2% | |
| GABAergic interneuron | 3 studies | 21% ± 3% | |
| lymphocyte | 3 studies | 23% ± 5% | |
| T cell | 3 studies | 16% ± 1% | |
| granule cell | 3 studies | 21% ± 2% |
